|
May 13
|
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
|
|
May 13
|
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
|
|
May 13
|
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
|
|
May 13
|
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
|
|
May 13
|
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty
|
|
May 10
|
Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination
|
|
May 10
|
Sanofi vaccine deal kicks off Novavax's 'new chapter': Analyst
|
|
May 10
|
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
|
|
May 10
|
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
|
|
May 10
|
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
|
|
May 10
|
Why Novavax Stock More Than Doubled Today
|
|
May 10
|
Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
|
|
May 10
|
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
|
|
May 10
|
Novavax-Sanofi vaccine deal, Yelp and Sweetgreen earnings: Morning Brief
|
|
May 10
|
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
|
|
May 10
|
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
|
|
May 10
|
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
|
|
May 10
|
Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar
|
|
May 10
|
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
|
|
May 10
|
Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
|